COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
CARE™ Platform
CMO
Partner
CONTACT
Contact
PUBLIC
Notice
News
EN
KO
COMPANY
About US
History
R&D
Pipeline
Intellectual Property
Organization
BUSINESS
CARE™ Platform
CMO
Partner
CONTACT
Contact
PUBLIC
NOTICE
NEWS
PUBLIC
Notice
News
NEWS
전체
전체
제목
내용
Signed a MOU with Modalis Therapeutics Corporation, jointly developing a XOB031-mediated AAV gene therapy for Alzheimer’s disease
2024-07-12
GXC-301 ODD request granted by US FDA
2024-07-02
GENIXCURE, Selected as a ‘2024 Global Unicorn’
2024-06-26
GXC-301 RPDD request granted by US FDA
2024-05-31
2024 Top Cell&Gene Therapy Company Award By Life Sciences Review
2024-05-30
A ‘co-developing’ Alzheimer’s disease therapeutic program with Hanyang Univ., funded by a governmental global R&D program from KHIDI
2024-04-23
Christopher Lim(CBDO) to speak at 4th Annual Next Generation Gene Therapy Vectors in Boston
2024-04-23
CEO Interview : Mr.Hongsung Moon
2024-04-03
Invited to Cell & Gene Tech Investment Forum by CHABiotech
2024-03-14
1
2